Companies: 10,795·Total market cap: $144.5T
Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

GALTNASDAQHealthcare● Active
$2.40
+$0.07(+3.00%)
Market Cap$158056555
P/E Ratio
52W High$7.13
52W Low$1.27
Overview

Galectin Therapeutics Inc.(GALT)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

galt · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 11 位华尔街分析师

SellBuy

Buy

11 位分析师

共识

评级分布

Strong Buy
0
Buy
9
Hold
2
Sell
0
Strong Sell
0
合计: 11 · 买入占比: 81.8%

12 个月目标价

High

$11.00

Consensus

$11.00

+359.3% upside

Low

$11.00

Median: $11 · Last Close: $2.40

Galectin Therapeutics Inc.(GALT)的分析师共识为 Buy,基于过去 3 个月内 11 位华尔街分析师的评级。GALT 的 12 个月平均目标价为 $11.00,相对当前价 $2.40 代表 +359.3% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$2.380.48%

1-day model range: $2.36–$2.4. Peak: $2.4 (-0.48%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

29%7%64%
4Buy
1Neutral
9Sell
RSI (14)56.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · GALT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.38BUY
MA 10$2.51SELL
MA 20$2.39BUY
MA 50$2.38BUY
MA 100$2.69SELL
MA 200$3.81SELL
Current $GALT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.40SELL
EMA 10$2.42SELL
EMA 20$2.41SELL
EMA 50$2.49SELL
EMA 100$2.81SELL
EMA 200$3.37SELL
Current $GALT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2025-12-17
Maintains
BuyBuy
HC Wainwright & Co.2025-08-14
Maintains
BuyBuy
HC Wainwright & Co.2025-04-02
Maintains
NeutralNeutral
HC Wainwright & Co.2024-12-27
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2024-11-15
Maintains
BuyBuy
HC Wainwright & Co.2024-08-16
Maintains
BuyBuy
HC Wainwright & Co.2024-04-09
Maintains
BuyBuy
HC Wainwright & Co.2024-04-01
Maintains
BuyBuy
HC Wainwright & Co.2023-08-15
Maintains
BuyBuy
HC Wainwright & Co.2023-05-17
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Galectin Therapeutics Inc. (GALT) stock. Of the recent 33 rating actions, 2 were upgrades and 6 were downgrades. 11 analysts currently cover GALT.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

GALT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$36M

↓ 90.6% YoY

Revenue Next Year

$180M

↑ 394.7% YoY

EPS This Year

$-0.49

EPS Next Year

$-0.37

↓ 24.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GALT EPS of $-0.49 for the current fiscal year, based on estimates from 1 analysts. The GALT revenue forecast is $36M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

GALT 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。GALT 的共识目标价为 $11.00(+359.3% 上行空间),分析师共识为 Buy。

GALT 的短期预测(明日)为 $2.38(-0.48%)。

Galectin Therapeutics Inc. 在 NASDAQ 上市,代码 GALT。GALT 在 2027 年的整体展望偏积极,在覆盖分析师中约 82% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

GALT 预测 · 8 个问题

根据 11 位华尔街分析师,GALT 的 12 个月平均目标价为 $11.00,最高 $11.00、最低 $11.00。若有图表,中位目标价可在上方查看。相对当前价 $2.40,隐含约 +359.3% 的上行空间。

GALT 目标价GALT 分析师目标价GALT 12个月目标价目标价 GALT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.